Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving chemotherapy after surgery may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of mitoxantrone given after surgery in
treating patients who have prostate cancer that is at high risk for recurrence.